Skip to content

YI

111, Inc.

NASDAQ · Healthcare · Medical - Pharmaceuticals · CN

$3.60
+1.69%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue10.4B12.2B14.4B14.9B13.5B
Cost of Revenue9.8B11.5B13.6B14.1B12.7B
Gross Profit598.9M703.7M829.2M849.0M840.0M
Operating Expenses
R&D Expense
SG&A Expense376.6M655.0M384.8M672.6M663.5M
General & Admin Expense60.5M58.7M70.9M224.2M205.6M
Selling & Marketing Expense316.1M596.2M313.9M448.4M457.9M
Other Expenses272.5M58.7M442.3M526.5M547.5M
Total Operating Expenses649.0M713.7M827.1M1.2B1.2B
Cost and Expenses10.5B12.2B14.4B15.3B13.9B
Operating Income (EBIT)(50.1M)(10.0M)2.1M(350.1M)(371.0M)
Non-Operating
Interest Income2.9M3.8M7.0M8.8M8.1M
Interest Expense35.0M34.6M28.3M20.1M13.4M
Net Interest Income(32.1M)(30.8M)(21.3M)(11.3M)(5.3M)
Other Non-Op Income/Expense(16.2M)(11.9M)(22.8M)(3.1M)(5.1M)
Non-Operating Income (excl Interest)(14.6M)(5.5M)(17.1M)(8.4M)
EBT (Pre-Tax Income)(66.3M)(21.9M)(20.7M)(353.2M)(376.1M)
Income Tax Expense12.6K96.0K251.0K
Bottom Line
Net Income(95.0M)(16.8M)(64.7M)(392.7M)(416.9M)
Earnings from Cont. Ops(66.3M)(21.9M)(20.8M)(353.4M)(376.1M)
Earnings from Discont. Ops
Bottom Line Net Income(105.1M)(64.6M)(64.7M)(392.7M)(416.9M)
Per Share
Basic EPS($11.92)($7.42)($7.52)($46.58)($50.04)
Diluted EPS($11.92)($7.42)($7.52)($46.58)($50.04)
Revenue Per Share$1,183.67$1,403.69$1,671.18$1,773.11$1,622.32
Shares
Basic Shares Outstanding8.8M8.7M8.6M8.4M8.3M
Diluted Shares Outstanding8.8M8.7M8.6M8.4M8.3M
Profitability Metrics
EBITDA(40.7M)1.8M24.6M(311.3M)(321.8M)
D&A11.8M17.0M21.8M40.8M
EBIT(40.7M)(10.0M)7.7M(333.0M)(362.6M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026